MiR-142-3p enhances chemosensitivity of breast cancer cells and inhibits autophagy by targeting HMGB1

• Main Authors: Lu Liang (Author), Jijun Fu (Author), Siran Wang (Author), Huiyu Cen (Author), Lingmin Zhang (Author), Safur Rehman Mandukhail (Author), Lingran Du (Author), Qianni Wu (Author), Peiquan Zhang (Author), Xiyong Yu (Author)
• Format: Book
• Published: Elsevier, 2020-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

MiR-142-3p has been reported to act as a tumor suppressor in breast cancer. However, the regulatory effect of miR-142-3p on drug resistance of breast cancer cells and its underlying mechanism remain unknown. Here, we found that miR-142-3p was significantly downregulated in the doxorubicin (DOX)-resi...